Health X Platform discloses voting results of 37th AGM
- All seven agenda items at the 37th AGM passed with over 99.99% majority
- 104 members participated via video conferencing out of 11,691 record shareholders
- Composite Scheme of Arrangement approved to consolidate digital healthcare assets
- Voting conducted solely through remote e-voting with no live meeting votes

*this image is generated using AI for illustrative purposes only.
Health X Platform Limited, formerly known as Sastasundar Ventures Limited, disclosed the detailed voting results of its 37th Annual General Meeting held on September 28, 2026. All seven agenda items were passed with requisite majority, as declared by the Chairman in compliance with SEBI (LODR) Regulations.
The meeting was conducted via Video Conferencing and Other Audio Visual Means, with 104 members participating in the proceedings. The primary focus was the approval of a Composite Scheme of Arrangement and Amalgamation involving Health X Platform, Microsec Resources Private Limited, Innogrow Technologies Limited, and Sastasundar Healthbuddy Limited. This strategic restructuring aims to consolidate digital healthcare assets under a unified corporate structure.
Voting Results and Participation
The company filed the combined voting results and the Consolidated Scrutinizer's Report with BSE and NSE on September 29, 2026. A total of 11,691 shareholders were on record as of the cut-off date, September 21, 2026. Of these, 104 members attended via video conferencing, comprising 10 from the promoter group and 94 public shareholders. No physical attendance or proxy appointments were permitted due to the virtual format.
Voting was conducted exclusively through remote e-voting provided by MUFG Intime India Private Limited. No votes were cast during the live meeting session. The results indicate overwhelming support for all resolutions, with opposition votes remaining negligible across all items.
| Resolution Type | Item | Status | Votes For (%) | Votes Against (%) |
|---|---|---|---|---|
| Ordinary | Adopt Audited Financial Statements for FY26 | Passed | 99.9996 | 0.0004 |
| Ordinary | Re-appointment of Mrs. Abha Mittal | Passed | 99.9996 | 0.0004 |
| Special | Re-appointment of Mrs. Anjana Dikshit as Independent Director | Passed | 99.9996 | 0.0004 |
| Special | Approve overall borrowing limit under Section 180(1)(c) | Passed | 99.9996 | 0.0004 |
| Special | Authorize creation of mortgage or charge on assets | Passed | 99.9996 | 0.0004 |
| Special | Authorize loans, guarantees, security, and investments | Passed | 99.9996 | 0.0004 |
| Special | Authorize loans/guarantees/security under Section 185 | Passed | 99.9996 | 0.0004 |
Strategic Digital Assets Highlighted
During the address, Chairman B. L. Mittal emphasized the company's strengthened position through its key digital platforms. The company outlined its portfolio of digitally driven services designed to enhance healthcare access and supply chain efficiency:
- SastaSundar App: A consumer-centric platform for seamless healthcare access.
- RetailerShakti App: A B2B supply chain solution empowering pharmacies.
- JitoHealth.com: A platform promoting generic medicines with AI-driven recommendations.
- SastaSundar Health & Happiness Podcast: An initiative to combat misinformation with trusted information.
Composite Scheme Details
The Board approved the composite scheme on June 10, 2026, following recommendations from the Committee of Independent Directors and the Audit Committee. The arrangement is subject to approvals from stock exchanges, SEBI, NCLT, RBI, and respective shareholders and creditors. NOC applications have been filed with the stock exchanges and RBI.
Governance and Compliance
The meeting was chaired by Mr. B. L. Mittal, with all directors and key managerial personnel present. The statutory auditors' report contained no qualifications, reservations, or adverse remarks. Similarly, the secretarial audit report was clean. The scrutinizer's report, prepared by MKB & Associates, confirmed that all votes were valid and that the resolutions were passed in accordance with the Companies Act, 2013.
Historical Stock Returns for Health X Platform
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -1.76% | -4.29% | -6.49% | +3.30% | -10.08% | 0.0% |
What is the expected timeline for NCLT and SEBI approvals regarding the composite scheme of arrangement?
How will the consolidation of Microsec Resources and Innogrow Technologies impact Health X Platform's operational synergies and cost structure?
What specific AI-driven features are planned for JitoHealth.com to enhance its competitive edge in the generic medicine market?


































